Skip to main content
Spyre Therapeutics, Inc. logo

Spyre Therapeutics, Inc. — Investor Relations & Filings

Ticker · SYRE ISIN · US00773J1034 LEI · 52990017AIJPRH3HQH40 US Manufacturing
Open in API
Filings indexed 740 across all filing types
Latest filing 2020-06-10 Director's Dealing
Country US United States of America
Listing US SYRE

About Spyre Therapeutics, Inc.

https://spyre.com/

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing next-generation therapeutics for patients with inflammatory bowel disease (IBD) and other immune-mediated conditions. The company's approach involves engineering novel antibodies with prolonged activity in the body, which allows for less frequent dosing. Its pipeline targets validated biological mechanisms and explores the use of these antibodies as both monotherapies and in rational combination therapies. Spyre aims to provide treatment options for various gastrointestinal and rheumatic diseases that offer the potential for enhanced efficacy and greater convenience.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2020-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-10 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 8, 2020, by Aeglea BioTherapeutics, Inc. It reports the results of the 2020 Annual Meeting of Stockholders, specifically the election of directors and ratification of the independent auditor. The key section is 'Item 5.07 Submission of Matters to a Vote of Security Holders,' which details voting results. The document length is 3648 characters, which is relatively short and focused on voting outcomes rather than full meeting materials or financial reports. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)' rather than an AGM Information presentation or a full Annual Report. Therefore, the correct classification is DVA with high confidence.
2020-06-09 English
SC 13G
Major Shareholding Notification
2020-06-09 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a SEC filing titled 'SCHEDULE 14A INFORMATION' and is described as 'Definitive Additional Materials' related to a Proxy Statement for the Annual Meeting of Stockholders. It provides a notice of change of location for the Annual Meeting, specifying that it will be held virtually due to COVID-19. The document references the Proxy Statement dated April 23, 2020, and instructs stockholders on how to participate and vote. It does not contain the Proxy Statement itself but supplements it with additional information about the meeting logistics. This type of document is best classified as Proxy Solicitation & Information Statement (PSI), as it relates to materials sent to shareholders to provide information and request votes for meetings.
2020-05-28 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 25, 2020, by Aeglea BioTherapeutics, Inc. It reports on a Regulation FD Disclosure regarding a presentation at the 6th Congress of the European Academy of Neurology (EAN Congress) about clinical trial data. The document includes a press release and a presentation as exhibits. The content focuses on clinical trial results and a presentation event rather than comprehensive financial data or detailed management discussion. The document is not an annual or quarterly report, nor is it an earnings release or a management report. It is a current report disclosing material events or corporate updates. Given the nature of the filing (Form 8-K) and the content (presentation and press release disclosure), the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories. The document length (7866 characters) and detailed content confirm it is not a mere announcement but a full current report filing. Therefore, the classification is RNS with high confidence.
2020-05-26 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.